Cite
HARVARD Citation
Hanna, G. et al. (2020). Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer. Cancer. 126 (17), pp. 3972-3981. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hanna, G. et al. (2020). Tipifarnib in recurrent, metastatic HRAS‐mutant salivary gland cancer. Cancer. 126 (17), pp. 3972-3981. [Online].